Head of Investor Relations
Bio-Rad Laboratories, Inc. (BIO)Equibles does not estimate personal net worth.
Get an email with a short summary when Bio-Rad Laboratories, Inc. publishes a filing, an earnings call transcript or a press release.
Get BIO alertsRuben Argueta is recorded as Head of Investor Relations at Bio-Rad Laboratories, Inc. (BIO). Ruben Argueta has spoken on 2 earnings calls across 1 company, most recently for Bio-Rad Laboratories, Inc. on August 4, 2026. Bio-Rad Laboratories, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bio-Rad Laboratories, Inc. includes Norman Schwartz (CEO, CFO and Board Member), Roop K. Lakkaraju (CFO and Chief Accounting Officer), Roop Lakkaraju (CFO) and 7 others.
“Today, we will review the financial results for the second quarter ended June 30, 2026 and provide an update on key business trends for BioRat.”
“It's a pleasure to join the team and be with you here. Today, we will review the financial results for the first quarter ended March 31st, 2026, and provide an update on key business trends for Bayrat.”
Medical Devices · Healthcare
Head of Investor Relations
